Nevro (NYSE: NVRO)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-03 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.100 | -0.980 | 0.1200 | ||||
REV | 86.180M | 87.842M | 1.662M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Nevro (NYSE: NVRO) through any online brokerage.
Other companies in Nevro’s space includes: Natus Medical (NASDAQ:NTUS), Heska (NASDAQ:HSKA), Varex Imaging (NASDAQ:VREX), AngioDynamics (NASDAQ:ANGO) and Inari Medical (NASDAQ:NARI).
The latest price target for Nevro (NYSE: NVRO) was reported by Morgan Stanley on Tuesday, June 7, 2022. The analyst firm set a price target for 55.00 expecting NVRO to rise to within 12 months (a possible 20.59% upside). 28 analyst firms have reported ratings in the last year.
The stock price for Nevro (NYSE: NVRO) is $45.61 last updated July 1, 2022, 7:59 PM UTC.
There are no upcoming dividends for Nevro.
Nevro’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Nevro.
Nevro is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.